Status:

RECRUITING

Bone Marrow and Peripheral Blood Immune Responses Study

Lead Sponsor:

Emory University

Collaborating Sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

Influenza

Eligibility:

All Genders

18-64 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to evaluate the immune response of the killed flu vaccine in healthy subjects. Participants in this study are considered to be healthy volunteers. Influenza ("Flu") infect...

Detailed Description

The purpose of this study is to evaluate the immune response of the killed flu vaccine in healthy subjects. Participants in this study are considered to be healthy volunteers. Influenza ("Flu") infect...

Eligibility Criteria

Inclusion Criteria:

  • All genders, races and ethnic groups (inclusive of women and minorities) are eligible for this trial, as influenza and the associated range of clinical issues accompanying influenza infection can impact people of all genders, races and ethnic groups. It is anticipated that the distribution of study participants will be diverse with regard to these demographics.
  • Adults able to provide consent on their own
  • Healthy adults

Exclusion Criteria:

  • Adults unable to consent
  • Women who are pregnant or nursing a child may not take part in this study. If a woman of childbearing potential is enrolled in this study, she and the study doctor must agree on a method of birth control to use throughout the study. Enrollees who think that they may have gotten pregnant during the study must tell the study doctor immediately. Pregnant women will be taken out of the study.
  • Prisoners
  • Cognitively impaired or individuals with impaired decision-making capacity
  • Individuals who are vulnerable to coercion or undue influence (human fetuses, or neonates of uncertain viability or non-viable neonates, minors/children, and cognitively impaired adults) will not be eligible for participation in this study.

Key Trial Info

Start Date :

October 16 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2029

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT05616546

Start Date

October 16 2023

End Date

December 1 2029

Last Update

January 31 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Emory University Hospital

Atlanta, Georgia, United States, 30322